Intelligent-C Endoscopy Module for Real-time Detection of Colonic Lesions

Study Overview
=================
Brief Summary
-----------------
To conduct an single blinded, non-randomized, prospective, single center trial to validate the performance of a novel state-of-the-art Artificial Intelligence model (AI-Model) for colorectal lesion detection during routine diagnostic colonoscopy and to evaluate its feasibility in daily endoscopy. Consecutive patients referred for a screening, surveillance or diagnostic colonoscopy will be included

Detailed Description
-----------------
All procedures will be performed with high-definition endoscopes; Bowel preparation will be conducted according to usual local practices. During colonoscopy, the colonoscope will be first advanced to the cecum in all patients as confirmed by identification of the appendicular orifice and ileocecal valve or by intubation of the ileum, as per the standard of care by experienced endoscopists. During the insertion, no action will be taken. After cecal intubation is performed, the colonoscope will be slowly withdrawn to the splenic flexure by the primary endoscopists. Real time AI detection model will be activated with the output displayed in real time on a separate monitor and will be only viewed by an independent investigator, who is an experienced endoscopists (or a person trained in polyp recognition). The primary endoscopists will be blinded to the AI real time detection result All detected polyps will be removed or with biopsy taken during this examination and sent for histopathology examination.

Official Title
-----------------
iIDEAS Intelligent-C Endoscopy Module for Real-time Detection of Colonic Lesions - A Prospective, Single Blinded, Non - Randomized, Single - Center Study

Conditions
-----------------
Artificial Intelligence, Colonic Polyp

Intervention / Treatment
-----------------
* Device: Real time AI detection model


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients undergoing colonoscopy of age 18 to 80 years. Patient who has read the informed consent form, has understood the relevant aspects of the study, and grants his/her authorization to participate by signing the informed consent form before the inclusion in the study and the performance of any procedure Consecutive adult patients scheduled to undergo routine colonoscopy at AIG Exclusion Criteria: Females who are pregnant Patients who are unsuitable for any other reason to participate in the study in the opinion of the investigator Recent colonoscopy within past 12 month History of inflammatory bowel disease History of colorectal cancer Previous bowel resection (apart from appendectomy) Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes Bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.

Ages Eligible for Study
-----------------
Minimum Age: 19 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Device: Real time AI detection model|Bowel preparation will be conducted according to usual local practices. During colonoscopy, the colonoscope will be first advanced to the cecum in all patients as confirmed by identification of the appendicular orifice and ileocecal valve or by intubation of the ileum, as per the standard of care by experienced endoscopists. During the insertion, no action will be taken. After cecal intubation is performed, the colonoscope will be slowly withdrawn to the splenic flexure by the primary endoscopists. Real time AI detection model will be activated with the output displayed in real time on a separate monitor and will be only viewed by an independent investigator, who is an experienced endoscopists (or a person trained in polyp recognition). The primary endoscopists will be blinded to the AI real time detection result|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Performance of a novel state-of-the-art Artificial Intelligence model (AI-Model) for colorectal lesion detection during routine diagnostic colonoscopy | A single-blinded, non-randomized prospective trial to validate the performance of a novel state-of-the-art Artificial Intelligence model (AI-Model) for colorectal lesion detection during routine diagnostic colonoscopy. | 1 Year |